Preventable childhood disability from untreated neonatal hyperbilirubinemia in africa: a public health and equity perspective
1
Department of Physiotherapy, University of Ilorin, Ilorin, Nigeria
2
Directorate of Research and Training, Nigerian Public Health Network, Ilorin, Nigeria
Popul. Med. 2026;8(Supplement Supplement 1):
ABSTRACT
INTRODUCTION:
Neonatal hyperbilirubinemia is a common neonatal condition and is largely preventable when detected and treated promptly. However, in many African settings, delayed diagnosis and limited access to treatment continue to result in kernicterus and permanent childhood disability. Despite its preventability, hyperbilirubinemia-related neurodevelopmental impairment remains underrepresented in newborn health priorities, disability frameworks, and equity-focused public health agendas. This abstract examines untreated neonatal hyperbilirubinemia in Africa as a marker of systemic inequities in newborn care.¹,²
METHODS:
A narrative scoping review was conducted to synthesize evidence on the burden, determinants, and outcomes of untreated neonatal hyperbilirubinemia in Africa. Peer-reviewed literature published between 2005 and 2025 was searched using pubmed, scopus, web of science, and african journals online. Gray literature from WHO and UNICEF was also reviewed. Eligible sources included epidemiological studies, health systems analyses, and policy reports. Findings were thematically analyzed using an equity lens.³
RESULTS:
Evidence shows that sub-saharan Africa bears a disproportionate share of severe neonatal hyperbilirubinemia and kernicterus globally.¹,³ Key drivers include limited postnatal follow-up, low caregiver awareness, shortages of functional phototherapy devices, and delayed referral pathways. Home births, early discharge, and reliance on traditional practices further increase risk.⁴,⁵ Affected children often develop irreversible motor, auditory, and cognitive impairments, yet remain largely invisible within disability surveillance, education planning, and social protection systems. These outcomes are strongly patterned by poverty, geography, and health system capacity.²,⁶
CONCLUSIONS:
Preventable childhood disability from untreated neonatal hyperbilirubinemia represents a neglected public health and equity challenge in Africa. Reframing hyperbilirubinemia as both a newborn survival and disability prevention issue is essential. Integrating bilirubin screening into routine newborn care, strengthening frontline capacity, ensuring equitable access to treatment technologies, and recognizing hyperbilirubinemia-related disability within child health and equity frameworks are critical to preventing avoidable lifelong impairment.⁵,⁷
Neonatal hyperbilirubinemia is a common neonatal condition and is largely preventable when detected and treated promptly. However, in many African settings, delayed diagnosis and limited access to treatment continue to result in kernicterus and permanent childhood disability. Despite its preventability, hyperbilirubinemia-related neurodevelopmental impairment remains underrepresented in newborn health priorities, disability frameworks, and equity-focused public health agendas. This abstract examines untreated neonatal hyperbilirubinemia in Africa as a marker of systemic inequities in newborn care.¹,²
METHODS:
A narrative scoping review was conducted to synthesize evidence on the burden, determinants, and outcomes of untreated neonatal hyperbilirubinemia in Africa. Peer-reviewed literature published between 2005 and 2025 was searched using pubmed, scopus, web of science, and african journals online. Gray literature from WHO and UNICEF was also reviewed. Eligible sources included epidemiological studies, health systems analyses, and policy reports. Findings were thematically analyzed using an equity lens.³
RESULTS:
Evidence shows that sub-saharan Africa bears a disproportionate share of severe neonatal hyperbilirubinemia and kernicterus globally.¹,³ Key drivers include limited postnatal follow-up, low caregiver awareness, shortages of functional phototherapy devices, and delayed referral pathways. Home births, early discharge, and reliance on traditional practices further increase risk.⁴,⁵ Affected children often develop irreversible motor, auditory, and cognitive impairments, yet remain largely invisible within disability surveillance, education planning, and social protection systems. These outcomes are strongly patterned by poverty, geography, and health system capacity.²,⁶
CONCLUSIONS:
Preventable childhood disability from untreated neonatal hyperbilirubinemia represents a neglected public health and equity challenge in Africa. Reframing hyperbilirubinemia as both a newborn survival and disability prevention issue is essential. Integrating bilirubin screening into routine newborn care, strengthening frontline capacity, ensuring equitable access to treatment technologies, and recognizing hyperbilirubinemia-related disability within child health and equity frameworks are critical to preventing avoidable lifelong impairment.⁵,⁷
| eISSN: | 2654-1459 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
